Clinical Trial Update: Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study [NA]

View source ↗

Summary

A multicenter randomized controlled trial evaluating whether Fufang Biejiaruangan plus antiviral therapy reduces hepatocellular carcinoma incidence in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Antiviral therapy
• Fufang Biejiaruangan

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Cirrhosis, Liver, Hepatocellular Carcinoma (HCC) | NA | Status: NOT_YET_RECRUITING